<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>At the age of 28, a 33-year-old male was diagnosed with malignant <z:mpath ids='MPATH_409'>fibrous histiocytoma</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFH</z:e>) with a <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesion</z:e> in the right maxillary sinus </plain></SENT>
<SENT sid="1" pm="."><plain>Although arterial infusion chemotherapy (pirarubicin <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> and <z:chebi fb="2" ids="31355">carboplatin</z:chebi>) was given, no <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage was observed, and surgery was therefore performed to remove the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Thereafter, the patient received autologous peripheral blood stem cell transplantation with high-dose chemotherapy (combination of ifosphamide, <z:chebi fb="2" ids="31355">carboplatin</z:chebi> and <z:chebi fb="0" ids="4911">etoposide</z:chebi>) as pretreatment </plain></SENT>
<SENT sid="3" pm="."><plain>An increase in the peripheral leukocyte count was noted 56 months after the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFH</z:e> was made </plain></SENT>
<SENT sid="4" pm="."><plain>Cytogenetic study showed translocation (9;22)(q34;q11) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) was therefore diagnosed </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFH</z:e> was in a state of complete remission </plain></SENT>
<SENT sid="7" pm="."><plain>The clinical course of this patient strongly suggests that this was a case of treatment-related <z:mp ids='MP_0005481'>CML</z:mp> that developed after chemotherapy for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFH</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment-related malignant <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood diseases</z:e> are known to include <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, but reports of treatment-related <z:mp ids='MP_0005481'>CML</z:mp> are rare, although there have been some cases of treatment-related <z:mp ids='MP_0005481'>CML</z:mp> occurring several years after pretreatment </plain></SENT>
</text></document>